Form 8-K - Current report:
SEC Accession No. 0001564590-22-018048
Filing Date
2022-05-05
Accepted
2022-05-05 08:38:44
Documents
17
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rdus-8k_20220505.htm   iXBRL 8-K 39412
2 EX-99.1 rdus-ex991_31.htm EX-99.1 125907
3 GRAPHIC gsysuc22d4z3000004.jpg GRAPHIC 1387339
4 GRAPHIC gsysuc22d4z3000001.jpg GRAPHIC 4595
5 GRAPHIC gsysuc22d4z3000003.jpg GRAPHIC 1398053
6 GRAPHIC gsysuc22d4z3000002.jpg GRAPHIC 1570363
  Complete submission text file 0001564590-22-018048.txt   6315646

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rdus-20220505.xsd EX-101.SCH 5601
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rdus-20220505_lab.xml EX-101.LAB 19324
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rdus-20220505_pre.xml EX-101.PRE 11495
11 EXTRACTED XBRL INSTANCE DOCUMENT rdus-8k_20220505_htm.xml XML 3546
Mailing Address ATTN: PRINCIPAL FINANCE OFFICER 22 BOSTON WHARF ROAD, 7TH FLOOR BOSTON MA 02210
Business Address ATTN: PRINCIPAL FINANCE OFFICER 22 BOSTON WHARF ROAD, 7TH FLOOR BOSTON MA 02210 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35726 | Film No.: 22894273
SIC: 2834 Pharmaceutical Preparations